Parkinsonism and cognitive impairment associated with valproic acid therapy: A one case study;Syndrome parkinsonien et déclin cognitif sous valproate: À propos d'un cas

Revue de Geriatrie

Volumn 31, Issue 3, 2006, Pages 179-180

  Merlet Chicoine, Isabelle ^a   Paccalin, Marc ^a   Perault Pochat, Marie Christine ^a   Chaumier, Jean Albert ^a   Pradere, Christine ^a   Poupet, Jean Yves ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; PARKINSONISM; SCORING SYSTEM;

EID: 33646475123     PISSN: 03977927     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Begaud B, Evreux JC, Jouglard, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode en France. Therapie 1985;40(2):111-8.
2. Zaret BS, Cohen RA. Reversible valproic acid-induced dementia: a case report. Epilepsia 1986;27:234-40.
3. Armon C, Shin C, Miller P, et al. Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996;47:626-35.
4. Masmoudi K, Gras-Champel V, Bonnet I, et al. Démence et troubles extrapyramidaux sous acide valproïque au long cours. Thérapie 2000;55:629-34.
5. Onofrj M, Thomas A, Paci C. Reversible parkinsonism induced by prolonged treatment with valproate. J Neurol 1998;245:794-6.
6. Vignal JP, Maillard L. Traitement antiépileptique chez le sujet âgé. Indications, choix et surveillance. Neurologies 2004;7:179-90.
7. Karceski S, Morrel M, Carpenter D. The Expert Consensus Guideline Series. Treatment of epilepsy. Epilepsy and behavior 2001;2:A1-A50.
8. ème génération. Neuronale 2001;1:21-27.
9. Nguyen N, Pradel V, Micallef J, et al. Les syndromes parkinsoniens médicamenteux. Thérapie 2004;59:105-112.
10. Maury Llerda JA, Tejero C, Mercade JM, et al. Lamotrigine and epilesy in the elderly: observational study of low-dose monotherapy. Int J Clin Pract 2005;59:651-4.